Because the NLRP3 inflammasome may trigger the release of IL-1β after stimulation with various danger signals, it represents a potentially effective target to regulate the onset and development of various autoimmune diseases, such as T1DM. Here, NLRP3 is linked to type 1 diabetes mellitus.